Tilray Brands (TLRY) EBITDA Margin (2017 - 2026)
Tilray Brands (TLRY) reported EBITDA Margin of 15.23% for Q1 2026, up 41481.0% on a YoY basis from N/an in Q1 2025, and up 15.18% quarter-over-quarter from 17.95% in Q4 2025.
Tilray Brands (TLRY) EBITDA Margin (2017 - 2026) Analysis & Trends
Tilray Brands has reported EBITDA Margin for 10 years, with the latest figure at 15.23% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 41481.0% year-over-year to 15.23%; the trailing twelve-month figure through Feb 2026 stood at 155.18% (down 3878.0% YoY), and the FY2025 full-year result was 266.2%, down 23554.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 15.23%, up from 17.95% in the prior quarter.
- The five-year high for EBITDA Margin was 20.86% in Q1 2022, with the low at 750.39% in Q1 2023.
- Historically, EBITDA Margin has averaged 146.72% across 5 years, with a median of 44.67% in 2024.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 77125 bps — and 2024, when it surged 69216 bps.
- Tilray Brands' EBITDA Margin stood at 72.07% in 2022, then jumped by 71 bps to 21.15% in 2023, then slumped by 111 bps to 44.67% in 2024, then soared by 60 bps to 17.95% in 2025, then rose by 15 bps to 15.23% in 2026.
- The last three EBITDA Margin figures came in at 15.23% (Q1 2026), 17.95% (Q4 2025), and 0.63% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Tilray Brands | - | - | 54.95 Mn | -15.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -15.23% |
| Nov 30, 2025 | -17.95% |
| Aug 31, 2025 | 0.63% |
| May 31, 2025 | -562.34% |
| Feb 28, 2025 | -430.04% |
| Nov 30, 2024 | -44.67% |
| Aug 31, 2024 | -15.24% |
| May 31, 2024 | -16.77% |
| Feb 29, 2024 | -58.23% |
| Nov 30, 2023 | -21.15% |
| Aug 31, 2023 | -29.76% |
| May 31, 2023 | -82.52% |
| Feb 28, 2023 | -750.39% |
| Nov 30, 2022 | -72.07% |
| Aug 31, 2022 | -83.94% |
| May 31, 2022 | -315.44% |
| Feb 28, 2022 | 20.86% |
| Nov 30, 2021 | -27.63% |
| Aug 31, 2021 | -80.96% |
| May 31, 2021 | 162.72% |